Industry & Intelligence
Reform Spreads, but the Picture Is Complicated
The United Nations Office on Drugs and Crime has released its World Drug Report 2026, and the headline figure is striking: 256 million people used cannabis in the past year, representing a 40% increase over the last decade. But the report's more uncomfortable finding may be this — legal reform and illicit market activity are not moving in opposite directions. In many respects, they are converging.
The WDR26 frames this growth as the product of a "continuum of gradual normalisation," one that has both reflected and accelerated a fragmented wave of policy liberalisation across jurisdictions. The word "wave," however, flatters what is in practice a patchwork: a dozen different regulatory experiments, at different stages, with different objectives, and increasingly uncertain trajectories.
A Map of Reform, Not a Movement
As of December 2025, full commercial adult-use legalisation remained confined largely to Canada, Uruguay, and 28 US jurisdictions. The more consequential story, for European observers at least, is what is happening at the margins of legalisation — the decriminalisation reforms, cultivation rights, and social club models that now define the European approach.
Germany's Cannabis Act, in force since April 2024, permits home cultivation of up to three plants and possession of 25 grammes, alongside non-commercial cultivation associations capped at 500 members. The Czech Republic's own reform took effect on 1 January 2026, permitting adults aged 21 and over to possess 25 grammes in public or 100 grammes at home. Luxembourg has allowed home cultivation since June 2023. Malta, notably, has been operating its Cannabis Harm Reduction Association model since 2021 — one of the earliest frameworks of its kind in the EU — with licensed associations permitted to supply members up to seven grammes per day.
Two experiments command particular attention. The Netherlands is piloting a regulated supply chain across ten municipalities, testing whether coffeeshops can operate legally from seed to sale. Switzerland, meanwhile, has enrolled 7,000 participants across seven cantons, with early results already suggesting meaningful differences between for-profit and not-for-profit models — particularly on product promotion and youth protection. The Swiss trial's conclusions may well set the template for the next phase of European cannabis policy.
Potency, Genetics, and a Blurring Supply Chain
One of the report's most technically significant findings concerns THC content. In the European Union (alongside Norway and the UK), the average THC concentration in seized cannabis reached 12.5% in 2024 — up from approximately 4% in 1995. In the United States, illicit-market cannabis averaged 16.1% THC by 2024, compared to 4% a decade ago.
The UNODC attributes this to the widespread adoption of feminised seeds, genetic selection for high-potency cultivars, and the shift toward controlled indoor cultivation. These are not artisanal developments; they reflect industrialised production methods on both sides of the legal divide.
What makes this particularly relevant for harm reduction practitioners is the report's finding on genetic overlap. Citing a US study tracking cannabinoid profiles between 2013 and 2022, the UNODC found that cannabis sold through licensed dispensaries and cannabis seized from illicit markets were of closely related genetic origin — though legal products tended to carry more THC and less CBD than their illicit counterparts. The supply chains, in other words, draw from the same genetic pool.
"Cannabis sold through licensed dispensaries and cannabis seized from the illegal market were of closely related genetic origin." — UNODC, World Drug Report 2026
In the EU context, the report flags a separate and more acute concern: low-THC herbal material being sold on the illicit market is increasingly being adulterated with synthetic and semi-synthetic cannabinoids. This practice — effectively spiking cannabis with substances that carry significantly higher potency and unknown safety profiles — is blurring the definition of what "cannabis" even means in an unregulated context. For harm reduction organisations, this represents a meaningful escalation in product risk.
What Growing Seizures Actually Tell Us
Global seizures of cannabis herb and resin reached historically high aggregate levels in 2023 and 2024, with Africa accounting for 61% of the total quantity seized worldwide in 2024. Cannabis resin seizures, by contrast, fell to their lowest level since 2011. In North America, seizures have declined steadily since 2010 — a trend the report links to shifting law enforcement priorities under legalisation regimes rather than any contraction in supply.
The implication is not straightforward. Seizure data has always been an imperfect proxy for market size, and the UNODC is careful not to overread it. What the figures do suggest is that legalisation reorganises enforcement activity more reliably than it eliminates illicit supply.
What This Means for Europe's Ongoing Experiment
For Malta and other early-reforming EU member states, the WDR26 offers both validation and caution. The CHRA model — designed explicitly around harm reduction, non-commercialisation, and member accountability — addresses several of the risk vectors the report identifies: it limits potency-chasing incentives, keeps commercial marketing out of the equation, and provides a controlled supply environment that reduces exposure to adulterated products.
Whether that model scales, and whether it remains insulated from the genetic and market pressures reshaping cannabis globally, is a question the Swiss and Dutch experiments may begin to answer in the years ahead. The UNODC's data makes clear that reform, on its own, is not sufficient. What matters is the architecture of that reform — and whether it is designed to genuinely displace illicit supply or merely to coexist with it.
The answer, the WDR26 suggests, is not yet obvious.
Sources
UNODC, World Drug Report 2026, United Nations Office on Drugs and Crime — referenced via Business of Cannabis: https://businessofcannabis.com/global-cannabis-use-up-40-over-last-decade-as-reform-spreads-but-overlap-with-illicit-market-growing/
Featured image: Photo by RDNE Stock project on Pexels
Members Discussion